½ÃÀ庸°í¼­
»óǰÄÚµå
1802955

¼¼°èÀÇ ÀÇ·á¿ë È­»óȸÀÇ ¼Ö·ç¼Ç ½ÃÀå ¿¹Ãø(-2032³â) : ±¸¼º¿ä¼Òº°, Àü°³ ¹æ½Äº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®

Healthcare Video Conferencing Solutions Market Forecasts to 2032 - Global Analysis By Component (Hardware, Software & Platforms and Services), Deployment Mode (Cloud-Based, On-Premises and Hybrid), Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ÀÇ·á¿ë È­»óȸÀÇ ¼Ö·ç¼Ç ½ÃÀåÀº 2025³â¿¡ 1¾ï 580¸¸ ´Þ·¯¸¦ Â÷ÁöÇϰí, ¿¹Ãø ±â°£ µ¿¾È CAGR 6.6%·Î ¼ºÀåÇÏ¿© 2032³â¿¡´Â 1¾ï 6,550¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÇ·á¿ë È­»óȸÀÇ ¼Ö·ç¼ÇÀº ½Ç½Ã°£ °¡»ó Áø·á, ¿ø°Ý Áø´Ü, Áö¿ª °£ °øµ¿ Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â HIPAA Áؼö ¾ÈÀü Ç÷§ÆûÀ» ÀǹÌÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ¿ø°Ý ÀÇ·á ¿öÅ©Ç÷ο츦 Áö¿øÇϰí ȯÀÚ À̵¿À» ÁÙÀ̸ç Àü¹®ÀÇ Á¢±Ù¼ºÀ» °³¼±Çϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¿µ»ó, µ¥ÀÌÅÍ °øÀ¯, ÀÓ»ó µµ±¸¸¦ ÅëÇÕÇÔÀ¸·Î½á Ä¡·á Á¦°øÀÇ È¿À²È­, ȯÀÚ Âü¿© °­È­, ¿î¿µ ºñ¿ë Àý°¨À» ½ÇÇöÇÕ´Ï´Ù.

¹Ì±¹ º¸°Çº¹ÁöºÎ(HHS)¿¡ µû¸£¸é, ¸ÞµðÄɾîÀÇ ¿ø°ÝÀÇ·á ÀÌ¿ëÀº 2019³â ¾à 84¸¸ °Ç¿¡¼­ 2020³â¿¡´Â 5,270¸¸ °ÇÀ¸·Î ±Þ°ÝÈ÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¿ø°ÝÀÇ·á ¹× µðÁöÅÐ Çコ µµÀÔ Áõ°¡

ÀÇ·á¿ë È­»óȸÀÇ ¼Ö·ç¼ÇÀº Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛ Àü¹Ý¿¡ °ÉÃÄ ¿ø°ÝÀÇ·á ¹× µðÁöÅÐ Çコ Ç÷§ÆûÀÇ Ã¤ÅÃÀÌ °¡¼ÓÈ­µÇ°í ÀÖ´Â Ãß¼¼¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â È­»óȸÀÇ ±â¼úÀ» ÅëÇÕÇÏ¿© ¿ø°ÝÁø·á, Àü¹®ÀÇ ¼Ò°³, Áö¼ÓÀûÀΠȯÀÚ Ä¡·á ¼­ºñ½º¸¦ Á¦°øÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ Áß½ÉÀÇ Áø·á ¸ðµ¨ÀÌ °­Á¶µÇ°í, Á¢±Ù¼ºÀ» Çâ»ó½ÃŰ¸é¼­ ÀÇ·áºñ¸¦ Àý°¨ÇÒ Çʿ伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á±â°üÀº ÷´Ü È­»óȸÀÇ ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, ½ÃÀå È®´ë¿Í ±â¼ú ¹ßÀüÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

¿ø°ÝÁö¿¡¼­ÀÇ ¿¬°á¼º ¹®Á¦

¿ø°ÝÁö³ª ³óÃÌ Áö¿ª¿¡¼­´Â Á¦ÇÑµÈ ÀÎÅÍ³Ý ÀÎÇÁ¶ó¿Í ºÒ¾ÈÁ¤ÇÑ ³×Æ®¿öÅ© ¿¬°áÀÌ ÀÇ·á¿ë È­»óȸÀÇ ¼Ö·ç¼Ç º¸±Þ¿¡ Å« °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ³·Àº ´ë¿ªÆø, ³×Æ®¿öÅ© Áö¿¬, °£ÇæÀûÀÎ ¿¬°á Àå¾Ö µîÀ¸·Î ÀÎÇØ °íǰÁú È­»óȸÀÇ ¹× ½Ç½Ã°£ ȯÀÚ ¸ð´ÏÅ͸µ ¼­ºñ½º Á¦°ø¿¡ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µµ½Ã¿Í Áö¹æÀÇ ÀÇ·á½Ã¼³ °£ÀÇ µðÁöÅÐ °ÝÂ÷´Â ¿ø°ÝÀÇ·á¿¡ ´ëÇÑ Á¢±Ù¼º°ú ¼­ºñ½º ǰÁú¿¡ °ÝÂ÷¸¦ ¹ß»ý½Ã۰í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­´Â ±â¼ú ÀÎÇÁ¶ó°¡ ºÎÁ·ÇÏ¿© ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ Á¾ÇÕÀûÀÎ È­»óȸÀÇ ½Ã½ºÅÛÀ» µµÀÔÇÒ ¼ö ¾ø±â ¶§¹®¿¡ ½ÃÀå ħÅõ¿Í ¼ºÀå °¡´É¼ºÀÌ Á¦ÇѵǾî ÀÖ½À´Ï´Ù.

ÀüÀÚÀǹ«±â·Ï°ú ÅëÇÕ

ÀÇ·á¿ë È­»óȸÀÇ ¼Ö·ç¼Ç°ú ÀüÀÚ ÀÇ·á ±â·Ï(EHR) ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀº ÀÓ»ó ¿öÅ©Ç÷οìÀÇ ÃÖÀûÈ­¿Í Á¾ÇÕÀûÀΠȯÀÚ µ¥ÀÌÅÍ °ü¸®¸¦ °­È­ÇÏ´Â Å« ½ÃÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ÅëÇÕÀ» ÅëÇØ ÀÇ·áÁøÀº °¡»ó Áø·á Áß¿¡ ȯÀÚÀÇ º´·Â, ÀÇ·á ±â·Ï, Áø´Ü Á¤º¸¿¡ ¿øÈ°ÇÏ°Ô Á¢±ÙÇÒ ¼ö ÀÖ¾î ÀÓ»óÀû ÀÇ»ç°áÁ¤ °úÁ¤À» °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÅëÇÕ Ç÷§ÆûÀº EHR »ýÅÂ°è ³»¿¡¼­ ÀÚµ¿ ¹®¼­È­, ó¹æ °ü¸®, Ä¡·á °èȹ ¾÷µ¥ÀÌÆ®¸¦ Á÷Á¢ÀûÀ¸·Î ÃËÁøÇÕ´Ï´Ù. ¶ÇÇÑ, È­»óȸÀÇ µµ±¸¿Í ±âÁ¸ ÀÇ·á IT ÀÎÇÁ¶ó °£ÀÇ »óÈ£¿î¿ë¼ºÀº ¿î¿µ È¿À²¼ºÀ» ³ôÀ̰í, °ü¸® ºÎ´ãÀ» ÁÙÀ̸ç, ±â¼ú °ø±Þ¾÷ü¿¡°Ô ºÎ°¡°¡Ä¡°¡ ³ôÀº ¼­ºñ½º Á¦¾ÈÀ» âÃâÇÕ´Ï´Ù.

µ¥ÀÌÅÍ º¸¾È ¹× ÇÁ¶óÀ̹ö½Ã ¹®Á¦

¹«´Ü Á¢±Ù, µ¥ÀÌÅÍ °¡·Îä±â, ¾Ç¼ºÄÚµå °ø°Ý µîÀÇ »çÀ̹ö º¸¾È Ãë¾àÁ¡Àº È­»óȸÀÇ Ç÷§ÆûÀ» µµÀÔÇÏ´Â ÀÇ·á ±â°ü¿¡ Å« À§ÇèÀ» ÃÊ·¡ÇÕ´Ï´Ù. HIPAA, GDPR, ±âŸ ÀÇ·á µ¥ÀÌÅÍ º¸È£ Áöħ°ú °°Àº ±ÔÁ¦ Áؼö ¿ä°ÇÀº ¼Ö·ç¼Ç Á¦°ø¾÷ü¿Í ÀÇ·á±â°ü¿¡ º¹ÀâÇÑ º¸¾È Àǹ«¸¦ ºÎ°úÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ¿Í ÀÇ·áÁø »çÀÌ¿¡¼­ ÇÁ¶óÀ̹ö½Ã À§Çè¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ µµÀÔ·üÀÌ Á¦Çѵǰí, µðÁöÅÐ Çコ Çõ½Å¿¡ ´ëÇÑ ÀúÇ×ÀÌ »ý±æ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ:

COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ »çȸÀû °Å¸®µÎ±â ¹× ¿ø°ÝÁø·á ÇÁ·ÎÅäÄÝÀ» ½ÃÇàÇϸ鼭 ÀÇ·á¿ë È­»óȸÀÇ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Å©°Ô °¡¼ÓÈ­µÇ¾ú½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº °¨¿° À§ÇèÀ» ÃÖ¼ÒÈ­Çϸ鼭 ȯÀÚ Ä¡·áÀÇ ¿¬¼Ó¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¿ø°ÝÀÇ·á Ç÷§ÆûÀ» ºü¸£°Ô µµÀÔÇÏ¿© Àü·Ê ¾ø´Â ½ÃÀå ¼ºÀå°ú ±â¼ú ¹ßÀüÀ¸·Î À̾îÁ³½À´Ï´Ù. ¶ÇÇÑ, ±ÔÁ¦ ´ç±¹Àº ¿ø°ÝÀÇ·á ¼­ºñ½º ½ÂÀÎÀ» ½Å¼ÓÈ÷ ó¸®ÇÏ°í ±ÔÁ¤ Áؼö ¿ä°ÇÀ» ¿ÏÈ­ÇÏ¿© ÆÒµ¥¹Í ±â°£ µ¿¾È ´Ù¾çÇÑ ÀÇ·á ȯ°æ°ú Àü¹® ºÐ¾ß¿¡ °ÉÃÄ È­»óȸÀÇ ¼Ö·ç¼ÇÀÇ ½Å¼ÓÇÑ µµÀÔÀ» ÃËÁøÇß½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ȯÀÚ ¹× °£º´ÀÎ ºÎ¹®ÀÌ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ȯÀÚ ¹× °£º´ÀÎ ºÎ¹®Àº Æí¸®Çϰí Á¢±ÙÇϱ⠽¬¿î ÀÇ·á ¼­ºñ½º ¹× ¿ø°Ý ȯÀÚ Âü¿© ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÎ¹®¿¡´Â È­»óȸÀÇ ±â¼úÀ» Ȱ¿ëÇÑ ¼ÒºñÀÚ Á÷Á¢ ¿ø°ÝÀÇ·á Ç÷§Æû, ¸¸¼ºÁúȯ °ü¸® ¾ÖÇø®ÄÉÀ̼Ç, °¡Á· °£º´ÀÎ Áö¿ø ½Ã½ºÅÛ µîÀÌ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ, Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ ¸¸¼ºÁúȯÀÇ À¯Çà°ú °í·ÉÈ­·Î ÀÎÇØ ÀçÅà µ¹º½ ¼­ºñ½º¸¦ ¼±È£ÇÏ´Â °í·ÉÈ­µµ ÀÌ ºÎ¹®ÀÇ ¿ìÀ§¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) Áö¿ø ºÐ¾ß°¡ °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) Áö¿ø ºÐ¾ß°¡ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â Áö¼ÓÀûÀÎ °Ç°­ ¸ð´ÏÅ͸µ°ú Àû±ØÀûÀΠȯÀÚ °ü¸® ¼ö¿ä Áõ°¡¿¡ ÈûÀÔÀº °ÍÀÔ´Ï´Ù. ÀÇ·áÁøÀº RPM ±â¼ú°ú ÅëÇÕµÈ È­»óȸÀǸ¦ Ȱ¿ëÇÏ¿© °¡»ó ¼øÈ¸ Áø·á¸¦ ½Ç½ÃÇϰí, Ȱ·Â ¡Èĸ¦ ¸ð´ÏÅ͸µÇϰí, ¸¸¼ºÁúȯÀ» ¾Î°í Àִ ȯÀÚ¿¡°Ô ½Ç½Ã°£ ÀÓ»ó Áö¿øÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÀΰøÁö´É, ¿þ¾î·¯ºí ±â±â, IoT ¼¾¼­¸¦ È­»óȸÀÇ Ç÷§Æû¿¡ ÅëÇÕÇÏ¿© ¿ø°Ý ¸ð´ÏÅ͸µ ±â´É°ú ÀÓ»ó °á°ú¸¦ °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. À¯¸®ÇÑ »óȯ Á¤Ã¥°ú RPM ÇÁ·Î±×·¥ÀÇ Áõ°Å¿¡ ±â¹ÝÇÑ ÀÓ»óÀû ÀÌÁ¡ÀÌ ÀÌ ºÎ¹®¿¡ ´ëÇÑ ½ÇÁúÀûÀÎ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À² Áö¿ª:

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, À̴ ÷´Ü ÀÇ·á ÀÎÇÁ¶ó, ±¤¹üÀ§ÇÑ ±¤´ë¿ª ¿¬°á, ¿ø°ÝÀÇ·á ÀÌ´Ï¼ÅÆ¼ºê¿¡ ´ëÇÑ °­·ÂÇÑ ±ÔÁ¦ Áö¿øÀ¸·Î ÀÎÇØ ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀº ÀÌ¹Ì ±¸ÃàµÈ ÀÇ·á IT »ýŰè, ¸·´ëÇÑ ÀÇ·áºñ ÁöÃâ, ÀÇ·á Á¦°øÀÚ¿Í È¯ÀÚ ¸ðµÎ µðÁöÅÐ Çコ ±â¼úÀ» Á¶±â¿¡ µµÀÔÇÏ´Â µîÀÇ ÀÌÁ¡À» ´©¸®°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÏ¹Ì¿¡ º»»ç¸¦ µÐ ÁÖ¿ä ±â¼ú º¥´õ¿Í ÀÇ·á±â°üÀÌ ¸·´ëÇÑ ¿¬±¸°³¹ß ÅõÀÚ¸¦ ÅëÇØ ±â¼ú Çõ½Å°ú ½ÃÀå °³Ã´À» ÃßÁøÇϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ºü¸£°Ô È®ÀåµÇ´Â ÀÇ·á ÀÎÇÁ¶ó, ÀÎÅÍ³Ý º¸±Þ·ü Áõ°¡, µðÁöÅÐ Çコ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ´ëÇÑ Á¤ºÎ ÅõÀÚ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ Áö¿ªÀº Àα¸°¡ ¸¹°í, °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡Çϸç, ¿ø°ÝÀÇ·áÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó È­»óȸÀÇ ¼Ö·ç¼Ç Á¦°ø¾÷ü¿¡°Ô Å« ½ÃÀå ±âȸ¸¦ âÃâÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±¹Á¦ÀûÀÎ ±â¼ú ±â¾÷°ú ÇöÁö ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ½ÃÀå ħÅõ¸¦ ÃËÁøÇÏ°í ´Ù¾çÇÑ Áö¿ª ¿ä°Ç¿¡ ¸Â´Â ¸ÂÃãÇü ¼Ö·ç¼Ç °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

±¸¼º¿ä¼Ò

  • Çϵå¿þ¾î
  • ¼ÒÇÁÆ®¿þ¾î/Ç÷§Æû
  • ¼­ºñ½º

¹«·á Ä¿½ºÅ͸¶ÀÌ¡ ¼­ºñ½º

º» º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù:

  • ±â¾÷ ¼Ò°³
    • Ãß°¡ ±â¾÷ Á¾ÇÕ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ±¸ºÐ
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º °ËÅä¿¡ µû¸¥)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­·Ð

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • ºÐ¼® ¹üÀ§
  • ºÐ¼® ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • ºÐ¼® Á¢±Ù¹ý
  • ºÐ¼® ÀÚ·á
    • 1Â÷ Á¶»ç ÀÚ·á
    • 2Â÷ Á¶»ç Á¤º¸ Ãâó
    • °¡Á¤

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ¾÷üÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëü Á¦Ç°ÀÇ À§Çù
  • ½Å±Ô ÁøÃâ ±â¾÷ÀÇ À§Çù
  • ±â¾÷°£ °æÀï

Á¦5Àå ¼¼°èÀÇ ÀÇ·á¿ë È­»óȸÀÇ ¼Ö·ç¼Ç ½ÃÀå : ±¸¼º¿ä¼Òº°

  • Çϵå¿þ¾î
    • Ä«¸Þ¶ó¡¤¸¶ÀÌÅ©
    • µð½ºÇ÷¹ÀÌ¡¤¸ð´ÏÅÍ
    • ¿ø°ÝÀÇ·á īƮ¡¤¸ð¹ÙÀÏ ¿£µåÆ÷ÀÎÆ®
    • Àü¿ë ȸÀÇ ´Ü¸»±â
    • ÀÎÇÁ¶ó¿ë Çϵå¿þ¾î
  • ¼ÒÇÁÆ®¿þ¾î¡¤Ç÷§Æû
    • µ¶¸³Çü È­»óȸÀÇ Ç÷§Æû
    • ÅëÇÕÇü ¿ø°ÝÀÇ·á ½ºÀ§Æ®
    • ÀÇ·á Àü¿ë ±â´É
  • ¼­ºñ½º
    • ±¸Çö¡¤ÅëÇÕ ¼­ºñ½º
    • ÈÆ·Ã¡¤ÄÁ¼³ÆÃ
    • ¼­Æ÷Æ®¡¤Á¤ºñ
    • ¸Å´ÏÁöµå ¼­ºñ½º

Á¦6Àå ¼¼°èÀÇ ÀÇ·á¿ë È­»óȸÀÇ ¼Ö·ç¼Ç ½ÃÀå : Àü°³ ¹æ½Äº°

  • Ŭ¶ó¿ìµå ±â¹Ý
  • ¿ÂÇÁ·¹¹Ì½º
  • ÇÏÀ̺긮µå

Á¦7Àå ¼¼°èÀÇ ÀÇ·á¿ë È­»óȸÀÇ ¼Ö·ç¼Ç ½ÃÀå : ¿ëµµº°

  • ¿ø°ÝÀÇ·á, Àü¹®ÀÇ¿¡ ÀÇÇÑ ÁøÂû
  • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) ¼­Æ÷Æ®
  • Á¤½Å°Ç°­¡¤Çൿġ·á
  • ÀÇÇÐ ±³À°¡¤¿¬¼ö
  • ÀÓ»ó½ÃÇ衤¿¬±¸ Çù·Â
  • ȯÀÚ Âü¿©¡¤±³À°
  • °ü¸® ¾÷¹«
  • ±Þ¼º±â ÀÌÈÄ Ä¡·á¡¤ÀçȰ Äɾî

Á¦8Àå ¼¼°èÀÇ ÀÇ·á¿ë È­»óȸÀÇ ¼Ö·ç¼Ç ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ÀÇ·á Á¦°øÀÚ
    • º´¿ø¡¤ÀÇ·á ½Ã½ºÅÛ
    • Ŭ¸®´Ð¡¤°³¾÷ÀÇ
    • Àå±â°£º´½Ã¼³¡¤Àü¹®¿ä¾ç½Ã¼³(º´¼³)
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC)
    • ÀçÅÃÀÇ·á ±â°ü
  • ȯÀÚ¡¤°£º´ÀÎ
  • ÁöºÒÀÚ¡¤º¸Çèȸ»ç
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Çмú¿¬±¸±â°ü

Á¦9Àå ¼¼°èÀÇ ÀÇ·á¿ë È­»óȸÀÇ ¼Ö·ç¼Ç ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÁÖ¿ä µ¿Çâ

  • °è¾à, »ç¾÷ Á¦ÈÞ¡¤Çù·Â, ÇÕÀÛÅõÀÚ
  • ±â¾÷ ÀμöÇÕº´(M&A)
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®Àå
  • ±âŸ ÁÖ¿ä Àü·«

Á¦11Àå ±â¾÷ °³¿ä

  • Cisco Systems Inc.
  • Zoom Video Communications Inc.
  • Microsoft Corporation(Microsoft Teams)
  • Polycom Inc.
  • Avaya Inc.
  • Adobe Inc.
  • Vidyo Inc.
  • VSee
  • Doxy.me
  • AMC Health
  • GlobalMed
  • Medici
  • Mend Family
  • eVisit
  • Teladoc Health
  • Caregility
  • BlueJeans by Verizon
  • Jitsi
KSM 25.09.09

According to Stratistics MRC, the Global Healthcare Video Conferencing Solutions Market is accounted for $105.8 million in 2025 and is expected to reach $165.5 million by 2032 growing at a CAGR of 6.6% during the forecast period. Healthcare video conferencing solutions refer to secure, HIPAA-compliant platforms that enable real-time virtual consultations, remote diagnostics, and collaborative care across geographies. These systems are designed to support telemedicine workflows, reduce patient travel, and improve access to specialists. By integrating video, data sharing, and clinical tools, they streamline care delivery, enhance patient engagement, and lower operational costs.

According to the U.S. Department of Health and Human Services (HHS), there was a dramatic increase in Medicare telehealth utilization, from approximately 840,000 visits in 2019 to 52.7 million visits in 2020.

Market Dynamics:

Driver:

Increasing adoption of telemedicine and digital health

The healthcare video conferencing solutions are driven by the accelerating adoption of telemedicine and digital health platforms across global healthcare systems. Healthcare providers are increasingly integrating video conferencing technologies to deliver remote consultations, specialist referrals, and continuous patient care services. Additionally, the growing emphasis on patient-centric care models and the need to reduce healthcare costs while improving accessibility have propelled healthcare institutions to invest in sophisticated video conferencing infrastructure, which has further accelerated market expansion and technological advancement.

Restraint:

Connectivity issues in remote areas

Limited internet infrastructure and unreliable network connectivity in remote and rural areas pose significant challenges to the widespread adoption of healthcare video conferencing solutions. Poor bandwidth availability, network latency, and intermittent connection disruptions hinder the delivery of high-quality video consultations and real-time patient monitoring services. Additionally, the digital divide between urban and rural healthcare facilities creates disparities in telemedicine access and service quality. Inadequate technological infrastructure in underserved regions restricts healthcare providers' ability to implement comprehensive video conferencing systems, limiting market penetration and growth potential in these areas.

Opportunity:

Integration with electronic health records

The integration of healthcare video conferencing solutions with electronic health records (EHR) systems presents substantial market opportunities for enhanced clinical workflow optimization and comprehensive patient data management. This convergence enables healthcare providers to access patient histories, medical records, and diagnostic information seamlessly during virtual consultations, improving clinical decision-making processes. Additionally, integrated platforms facilitate automated documentation, prescription management, and treatment plan updates directly within the EHR ecosystem. Moreover, interoperability between video conferencing tools and existing healthcare IT infrastructure drives operational efficiency, reduces administrative burden, and creates value-added service propositions for technology vendors.

Threat:

Data security and privacy concerns

Cybersecurity vulnerabilities, including unauthorized access, data interception, and malware attacks, pose substantial risks to healthcare organizations implementing video conferencing platforms. Regulatory compliance requirements such as HIPAA, GDPR, and other healthcare data protection mandates create complex security obligations for solution providers and healthcare institutions. Moreover, increasing awareness of privacy risks among patients and healthcare professionals may limit adoption rates and create resistance to digital health transformation initiatives.

Covid-19 Impact:

The COVID-19 pandemic significantly accelerated the adoption of healthcare video conferencing solutions as healthcare systems worldwide implemented social distancing measures and remote care protocols. Healthcare providers rapidly deployed telemedicine platforms to maintain patient care continuity while minimizing infection risks, leading to unprecedented market growth and technological advancement. Additionally, regulatory agencies expedited approvals for telehealth services and relaxed compliance requirements, facilitating faster implementation of video conferencing solutions across various healthcare settings and specialties during the pandemic period.

The patients & caregivers segment is expected to be the largest during the forecast period

The patients & caregivers segment is expected to account for the largest market share during the forecast period, driven by increasing consumer demand for convenient, accessible healthcare services and remote patient engagement solutions. This segment encompasses direct-to-consumer telemedicine platforms, chronic disease management applications, and family caregiver support systems that utilize video conferencing technologies. Additionally, the growing prevalence of chronic conditions requiring continuous monitoring and the aging population's preference for home-based care services contribute to segment dominance.

The remote patient monitoring (RPM) support segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the remote patient monitoring (RPM) support segment is predicted to witness the highest growth rate, fueled by increasing demand for continuous health monitoring and proactive patient care management. Healthcare providers are leveraging video conferencing integrated with RPM technologies to conduct virtual rounds, monitor vital signs, and provide real-time clinical support to patients with chronic conditions. Additionally, the integration of artificial intelligence, wearable devices, and IoT sensors with video conferencing platforms enhances remote monitoring capabilities and clinical outcomes. Favorable reimbursement policies and evidence-based clinical benefits of RPM programs drive substantial investment in this segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, attributed to advanced healthcare infrastructure, widespread broadband connectivity, and strong regulatory support for telemedicine initiatives. The region benefits from established healthcare IT ecosystems, significant healthcare spending, and early adoption of digital health technologies by both providers and patients. Additionally, major technology vendors and healthcare organizations headquartered in North America drive innovation and market development through substantial research and development investments.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapidly expanding healthcare infrastructure, increasing internet penetration, and growing government investments in digital health initiatives. The region's large population base, rising disposable incomes, and increasing awareness of telemedicine benefits create substantial market opportunities for video conferencing solution providers. Moreover, strategic partnerships between international technology companies and local healthcare providers facilitate market penetration and customized solution development for diverse regional requirements.

Key players in the market

Some of the key players in Healthcare Video Conferencing Solutions Market include Cisco Systems Inc., Zoom Video Communications inc., Microsoft Corporation (Microsoft Teams), Polycom Inc., Avaya Inc., Adobe Inc., Vidyo Inc., VSee, Doxy.me, AMC Health, GlobalMed, Medici, Mend Family, eVisit, Teladoc Health, Caregility, BlueJeans by Verizon, and Jitsi.

Key Developments:

In August 2025, Cisco has introduced Cisco Spatial Meetings, compatible with Apple Vision Pro, pushing boundaries in immersive virtual collaboration which can benefit telehealth applications.

In July 2025, Zoom launched 'Zoom Workplace for Frontline', a tool helping frontline healthcare staff enhance shift-based communications and productivity. Features include auto-created team chat groups, real-time activity feeds, and push-to-talk, supporting healthcare teams during shifts. The release was announced by Zoom's head of product at HIMSS25.

In April 2025, At Adobe Summit 2025, Adobe showcased its Experience Cloud for Healthcare, emphasizing secure, HIPAA-ready, patient-centric digital experiences and integrations with industry partners like Microsoft. Adobe's platforms enable healthcare providers to deliver personalized care and manage workflows securely.

Components:

  • Hardware
  • Software & Platforms
  • Services

Deployment Modes Covered:

  • Cloud-Based
  • On-Premises
  • Hybrid

Applications Covered:

  • Telemedicine & Specialist Consultations
  • Remote Patient Monitoring (RPM) Support
  • Mental Health & Behavioral Therapy
  • Medical Education & Training
  • Clinical Trials & Research Collaboration
  • Patient Engagement & Education
  • Administrative Operations
  • Post-Acute & Rehabilitation Care

End Users Covered:

  • Healthcare Providers
  • Patients & Caregivers
  • Payers & Insurance Providers
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Healthcare Video Conferencing Solutions Market, By Component

  • 5.1 Introduction
  • 5.2 Hardware
    • 5.2.1 Cameras & Microphones
    • 5.2.2 Displays & Monitors
    • 5.2.3 Telehealth Carts & Mobile Endpoints
    • 5.2.4 Dedicated Conferencing Terminals
    • 5.2.5 Infrastructure Hardware
  • 5.3 Software & Platforms
    • 5.3.1 Standalone Video Conferencing Platforms
    • 5.3.2 Integrated Telehealth Suites
    • 5.3.3 Healthcare-Specific Features
  • 5.4 Services
    • 5.4.1 Implementation & Integration Services
    • 5.4.2 Training & Consulting
    • 5.4.3 Support & Maintenance
    • 5.4.4 Managed Services

6 Global Healthcare Video Conferencing Solutions Market, By Deployment Mode

  • 6.1 Introduction
  • 6.2 Cloud-Based
  • 6.3 On-Premises
  • 6.4 Hybrid

7 Global Healthcare Video Conferencing Solutions Market, By Application

  • 7.1 Introduction
  • 7.2 Telemedicine & Specialist Consultations
  • 7.3 Remote Patient Monitoring (RPM) Support
  • 7.4 Mental Health & Behavioral Therapy
  • 7.5 Medical Education & Training
  • 7.6 Clinical Trials & Research Collaboration
  • 7.7 Patient Engagement & Education
  • 7.8 Administrative Operations
  • 7.9 Post-Acute & Rehabilitation Care

8 Global Healthcare Video Conferencing Solutions Market, By End User

  • 8.1 Introduction
  • 8.2 Healthcare Providers
    • 8.2.1 Hospitals & Health Systems
    • 8.2.2 Clinics & Physician Practices
    • 8.2.3 Long-Term Care & Skilled Nursing Facilities (added)
    • 8.2.4 Ambulatory Surgical Centers (ASCs)
    • 8.2.5 Home Healthcare Agencies
  • 8.3 Patients & Caregivers
  • 8.4 Payers & Insurance Providers
  • 8.5 Pharmaceutical & Biotechnology Companies
  • 8.6 Academic & Research Institutions

9 Global Healthcare Video Conferencing Solutions Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Cisco Systems Inc.
  • 11.2 Zoom Video Communications Inc.
  • 11.3 Microsoft Corporation (Microsoft Teams)
  • 11.4 Polycom Inc.
  • 11.5 Avaya Inc.
  • 11.6 Adobe Inc.
  • 11.7 Vidyo Inc.
  • 11.8 VSee
  • 11.9 Doxy.me
  • 11.10 AMC Health
  • 11.11 GlobalMed
  • 11.12 Medici
  • 11.13 Mend Family
  • 11.14 eVisit
  • 11.15 Teladoc Health
  • 11.16 Caregility
  • 11.17 BlueJeans by Verizon
  • 11.18 Jitsi
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦